Table 2.
Linear regression analysis of absolute change in eGFR
| Variables | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| B | 95%CI | P | B | 95%CI | P | |
| Gender (female vs. male) | 5.724 | −3.977-15.426 | 0.245 | |||
| Age | −0.208 | − 0.599-0.183 | 0.295 | |||
| Body mass index | 0.105 | −1.090-1.301 | 0.862 | |||
| ASA classification | −6.273 | −15.458-2.912 | 0.179 | |||
| Side (right vs. left) | 1.175 | −7.626-9.975 | 0.792 | |||
| Tumor diameter | 0.975 | −0.228-2.178 | 0.111 | |||
| Tumor thrombus grade | 0.521 | −3.013-4.055 | 0.771 | |||
| Preoperative serum creatinine | 0.079 | 0.027–0.132 | 0.003* | – | – | – |
| Preoperative eGFR | −0.476 | −0.653--0.299 | < 0.001* | −0.455 | − 0.631--0.278 | < 0.001* |
| Operation approach (open vs. laparoscopy) | 2.11 | −6.387-10.607 | 0.624 | |||
| Operation time | 0.022 | −0.013-0.056 | 0.213 | |||
| Pathological type (non-clear cell carcinoma vs. clear cell carcinoma) | 14.612 | 2.964–26.260 | 0.014* | 11.416 | 0.658–22.174 | 0.038* |
| Vascular wall invasion (present vs. absent) | 6.462 | −2.135-15.058 | 0.139 | |||
| Lymphatic vascular invasion (present vs. absent) | −4.479 | −14.733-5.775 | 0.389 | |||
| Perinephric tissues invasion (present vs. absent) | −2.692 | −11.876-6.491 | 0.563 | |||
| Renal pelvis invasion (present vs. absent) | 7.211 | −2.872-17.293 | 0.16 | |||
| Necrosis (present vs. absent) | −1.846 | −10.338-6.646 | 0.668 | |||
| Sarcomatoid differentiation (present vs. absent) | −1.769 | −13.193-9.655 | 0.76 | |||
eGFR estimated glomerular filtration rate, ISUP International Society of Urological Pathology; *p<0.05